Follow and like us on our Facebook page where we post on the new release subject and answering tips and tricks to help save your time so that you can never feel stuck again.
Shortcut

Ctrl + F is the shortcut in your browser or operating system that allows you to find words or questions quickly.

Ctrl + Tab to move to the next tab to the right and Ctrl + Shift + Tab to move to the next tab to the left.

On a phone or tablet, tap the menu icon in the upper-right corner of the window; Select "Find in Page" to search a question.

Share Us

Sharing is Caring

It's the biggest motivation to help us to make the site better by sharing this to your friends or classmates.

Triple-Negative Breast Cancer

Learn about triple-negative breast cancer, its causes, treatment options, and research advancements for better awareness and support.

cancer

triple-negative

breast

diagnosis

treatment

therapy

symptoms

research

survival

prognosis

genetics

chemotherapy

radiotherapy

oncology

awareness

What is the role of immune therapy in TNBC treatment?

  • It may be used in some cases to stimulate the immune system to target cancer cells.
  • It is used to reduce tumor size before surgery.
  • It has no role in TNBC treatment.
  • It is used to treat only hormone-positive cancers.

Which type of breast cancer has a better prognosis compared to TNBC?

  • Hormone receptor-positive breast cancer.
  • TNBC is the most treatable form of breast cancer.
  • HER2-positive breast cancer.
  • Metastatic breast cancer.

What is the likelihood of recurrence for TNBC after initial treatment?

  • TNBC has a higher likelihood of recurrence within the first few years.
  • TNBC has a low recurrence rate.
  • Recurrence happens only after 10 years.
  • There is no risk of recurrence.

Which ethnic group has a higher prevalence of TNBC?

  • Caucasian women.
  • African American women.
  • Asian women.
  • Hispanic women.

What is a major barrier to TNBC treatment?

  • Lack of targeted therapies for this subtype.
  • High cost of surgery.
  • Resistance to chemotherapy.
  • Overexpression of estrogen receptors.

What does the term "negative" refer to in Triple-Negative Breast Cancer?

  • The absence of three receptors: estrogen, progesterone, and HER2.
  • The tumor is benign.
  • It is a term for non-invasive cancers.
  • The absence of lymph node involvement.

What role does chemotherapy play in the treatment of TNBC?

  • It helps kill fast-growing cancer cells.
  • It prevents the growth of estrogen receptors.
  • It repairs DNA damage in the tumor cells.
  • It stimulates the immune system to target the cancer.

How is the HER2 gene related to TNBC?

  • It is overexpressed in TNBC cells.
  • It is not overexpressed in TNBC cells.
  • It makes TNBC cells more resistant to chemotherapy.
  • It helps tumors metastasize more quickly.

Which treatment is NOT effective for TNBC?

  • Hormonal therapy.
  • Hormonal therapy is ineffective for TNBC.
  • Chemotherapy.
  • Surgery.

How is TNBC typically diagnosed?

  • Mammography and biopsy.
  • Mammography, ultrasound, and biopsy.
  • PET scan and MRI.
  • Blood test and ultrasound.

What is the key to successful treatment of TNBC?

  • Early detection and aggressive treatment.
  • Targeted therapy for HER2.
  • Hormonal therapy for estrogen-positive patients.
  • Delayed surgery after chemotherapy.

Which receptor is absent in TNBC tumors?

  • Estrogen, progesterone, and HER2 receptors.
  • Estrogen receptors only.
  • Progesterone receptors only.
  • HER2 receptors only.

What lifestyle factor is associated with a lower risk of TNBC?

  • Regular exercise and a healthy diet.
  • Maintaining a healthy weight.
  • Smoking cessation.
  • Avoiding hormonal treatments.

What is one reason why TNBC has a poorer prognosis?

  • It does not respond to hormonal treatments.
  • It is less aggressive than other cancers.
  • It can be treated with surgery alone.
  • It has a higher survival rate.

Which protein is often missing in TNBC cells?

  • HER2 protein.
  • EGFR protein.
  • Estrogen receptors.
  • Progesterone receptors.

Which of the following is true about the spread of TNBC?

  • It can spread quickly to other organs, such as the lungs or liver.
  • It typically remains localized in the breast.
  • It only spreads to nearby lymph nodes.
  • It spreads mainly to the bones.

How is TNBC typically classified in staging?

  • Staging is based on tumor size, lymph node involvement, and metastasis.
  • It is classified only based on tumor size.
  • It is staged only based on genetic mutations.
  • It is not staged.

What is the most common chemotherapy drug used for TNBC?

  • Doxorubicin.
  • Tamoxifen.
  • Herceptin.
  • Sunitinib.

Which of the following genetic mutations is associated with TNBC?

  • BRCA1 mutation.
  • BRCA2 mutation.
  • EGFR mutation.
  • p53 mutation.

What is a common challenge in treating TNBC?

  • Hormone therapy resistance.
  • Lack of targeted therapies.
  • Presence of HER2 receptors.
  • Tumor cells being estrogen-sensitive.

Which medication is NOT used to treat TNBC?

  • Tamoxifen (used for hormone-positive cancers).
  • Doxorubicin.
  • Paclitaxel.
  • Carboplatin.

What is the main method of screening for breast cancer, including TNBC?

  • Mammography.
  • MRI.
  • CT scan.
  • Biopsy.

What is the standard surgical procedure for TNBC?

  • Mastectomy or lumpectomy, depending on tumor size.
  • Lymph node dissection only.
  • Only radiation therapy.
  • Chemo-induced tumor removal.

Which age group is most commonly diagnosed with TNBC?

  • Women under the age of 40.
  • Women over the age of 60.
  • Women in their 30s and 40s.
  • Women over 70 years old.

Which of the following is NOT a symptom of TNBC?

  • A lump in the breast.
  • A fever that does not subside.
  • Pain in the breast or underarm.
  • Skin changes in the breast.

How does the growth rate of TNBC compare to other forms of breast cancer?

  • TNBC tends to grow more quickly.
  • TNBC grows slowly and is easier to treat.
  • TNBC has the same growth rate as estrogen-positive tumors.
  • TNBC is less aggressive than other types.

What is the most important factor for determining treatment for TNBC?

  • The stage of cancer at diagnosis.
  • Patient age.
  • The size of the tumor alone.
  • Whether the tumor is malignant or benign.

What does "BRCA-positive" mean in the context of TNBC?

  • It means the cancer is linked to a hereditary gene mutation.
  • It means the cancer responds well to chemotherapy.
  • It means the tumor is estrogen-sensitive.
  • It means the tumor is slow-growing.

How do doctors classify TNBC in terms of its aggressiveness?

  • It is classified as a high-grade cancer.
  • It is classified as low-grade.
  • It is classified as benign.
  • It is classified as moderate-grade.

What is the most effective treatment combination for TNBC?

  • Chemotherapy followed by surgery and radiation.
  • Monoclonal antibody treatment.
  • Hormonal therapy followed by radiation.
  • Surgery alone.

What is the survival rate for patients diagnosed with TNBC compared to other types of breast cancer?

  • It has a lower survival rate.
  • It has the same survival rate.
  • It has a higher survival rate.
  • The survival rate is still being studied.

What type of therapy is most commonly used to treat TNBC?

  • Chemotherapy.
  • Hormone therapy.
  • Immunotherapy.
  • Radiation therapy.

What is a recent advancement in the treatment of TNBC?

  • Immunotherapy and targeted therapies.
  • Only surgery and chemotherapy.
  • Hormonal treatment options.
  • Increased radiation options.

What is one reason why TNBC is referred to as a "difficult" cancer to treat?

  • It does not respond to hormonal therapies like other types of breast cancer.
  • It grows slowly and can be easily managed.
  • It only affects older women.
  • It is always treatable with chemotherapy.

What is the prognosis for patients diagnosed with TNBC compared to other types of breast cancer?

  • TNBC generally has a poorer prognosis.
  • TNBC has the same prognosis as estrogen-positive breast cancer.
  • TNBC patients tend to have better outcomes.
  • TNBC has a better prognosis due to better treatment options.

What genetic test may be performed to evaluate the risk of TNBC?

  • BRCA genetic testing.
  • CTC analysis.
  • Proteomic testing.
  • Colonoscopy.

What is Triple-Negative Breast Cancer (TNBC)?

  • A subtype of breast cancer that lacks estrogen, progesterone, and HER2 receptors.
  • A type of breast cancer that is estrogen positive.
  • A form of cancer that involves only the lymphatic system.
  • A rare type of tumor that forms in the brain.

Which of the following is a characteristic feature of TNBC?

  • It does not express estrogen receptors, progesterone receptors, or HER2.
  • It is slow-growing and easy to treat.
  • It has high expression of estrogen and progesterone receptors.
  • It tends to be diagnosed at later stages.

What is a common treatment for Triple-Negative Breast Cancer?

  • A combination of chemotherapy, surgery, and radiation therapy.
  • Hormone therapy.
  • Targeted therapy for HER2 receptors.
  • Monoclonal antibody therapy.

Which of the following is a risk factor for developing TNBC?

  • A family history of breast cancer.
  • High intake of fatty foods.
  • Regular physical activity.
  • Having children at an older age.

Which factor can increase the likelihood of a better outcome for TNBC?

  • Early detection and treatment.
  • Lack of symptoms.
  • Hereditary mutations.
  • Presence of estrogen receptors.

What is the role of radiation therapy in TNBC treatment?

  • It is used after surgery to kill any remaining cancer cells.
  • It is the first line of treatment.
  • It is used as the sole treatment.
  • It is used to shrink the tumor before surgery.

What is one reason why TNBC is harder to treat?

  • It is less responsive to chemotherapy.
  • It does not respond to hormone therapies.
  • It is less likely to spread to lymph nodes.
  • It tends to be found in smaller tumors.
Comments